You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Nitric Oxide-Releasing Intranasal Gel To Decolonize Biofilm-embedded S. Aureus
SBC: Novan, Inc. Topic: NIAIDDESCRIPTION (provided by applicant): Staphylococcus aureus is the second leading cause of hospital-acquired bloodstream infections. In 2003, nearly 300,000 patients in US hospitals acquired an S. aureus infection, which accounted for nearly three million days of hospitalization, 9.5 billion in excess costs, and at least 12,000 inpatient deaths. Additionally, approximately 50% of the US population ...
SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health -
Development of a human skeletal muscle cell-based high throughput screen for musc
SBC: Zen-Bio, Inc. Topic: NIAMSDESCRIPTION (provided by applicant): Skeletal muscle wasting is a serious condition prevalent in the aging population (sarcopenia) and in a variety of specific diseases. This condition results in loss of muscle function through impaired muscle regeneration, resulting in an increase in falls and injuries, a loss of independence, and a reduced quality of life. These changes produce a large health ca ...
SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health -
Improved Noise Attenuation Foam for In the Ear Hearing and Noise Devices
SBC: HEARING COMPONENTS, INC. Topic: NIDCDDESCRIPTION (provided by applicant): Viscoelastic foam earplugs are commonly used for personal hearing protection to help reduce the incidence of hearing loss; however, many work environments exist where the protection from currently available earplugsis insufficient. In addition, the ability of existing foam earplugs to attenuate low frequency energy is relatively poor. Pilot experiments were ...
SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health -
Bone cements for delivery of osteoinductive growth factors
SBC: AFFINERGY, LLC Topic: NIDCRDESCRIPTION (provided by applicant): Bone cements are widely used in maxillofacial surgery, repair of cranial defects, and dental fillings. Calcium phosphate bone cements are useful in many types of bone repair because they conform to the defect area, harden in situ, and can be resorbed and replaced by new bone. When the cements are injectable, they can also be used for minimally invasive surgery ...
SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health -
Impact of digital media-based nutrition education on low science literacy, under-
SBC: CARA CAIRNS DESIGN, LLC Topic: NIDDKDESCRIPTION (provided by applicant): The purpose of this project is to research and develop digital media-based nutrition education materials for low science literacy, underserved, and minority patients receiving dialysis treatment for ESRD. The developedmaterials will lay the foundation and serve as prototypes for a Phase II NIH SBIR application aimed at full development and marketing of an inter ...
SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health -
Improving Obesity Outcomes through Interactive Web-Based Clinical Skills Training
SBC: Clinical Tools, Inc Topic: NIDDKDESCRIPTION (provided by applicant): Though the USPSTF recommends all clinicians intervene with obese adults (AHRQ, 2003), less than half of patients are assessed, counseled, or otherwise treated for obesity. This project will create an innovative web-based continuing professional development program for primary care providers (PCPs) available at: //www.ImpactObesity.com to improve PCP care of obe ...
SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health -
Hydraulic Artificial Urinary Sphincter (HydrAUS)
SBC: GT UROLOGICAL, LLC Topic: NIDDKHydraulic Artificial Urinary Sphincter - HydrAUS GT Urological, LLC. has prepared this NIH SBIR Phase I Grant Application entitled Hydraulic Artificial Urinary Sphincter - HydrAUS to detail goals and activities related to the design and development ofan implantable, hydraulic urinary sphincter intended to safely and effectively prevent urinary leakage in males and females suffering from Urin ...
SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health -
Improving Host Response to Implantable Glucose Sensors via Nitric Oxide Release
SBC: Novan, Inc. Topic: NIDDKDESCRIPTION (provided by applicant): Approximately 24 million adults and children in the United States have 1 Diabetes Mellitus (diabetes) and 1.6 million new cases are diagnosed each year. Type 2 is the most common form of the disease accounting for over90% of the diabetics worldwide. The remaining 5 to 10% of diabetics are plagued with the more serious Type 1 condition which is most often diagno ...
SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health -
Novel PPAR-Independent Peroxisome Proliferators for Type 2 Diabetes
SBC: SOUTHEAST TECHINVENTURES INC Topic: NIDDKDESCRIPTION (provided by applicant): The goal of this small business innovation research (SBIR) grant is to develop novel compounds that can significantly improve the effectiveness of Type-II diabetes treatment. The need for anti-diabetic drugs is enormouswith over 23 million American diabetics and predictions that one-in-three Americans born after 2003 will develop Type-II Diabetes (T2D). New dia ...
SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health -
Selective Fyn kinase inhibitors for treatment of metabolic disease
SBC: Zen-Bio, Inc. Topic: NIDDKDESCRIPTION (provided by applicant): Metabolic diseases such as type 2 diabetes (T2D), obesity and their related co-morbidities have reached epidemic proportions worldwide. While progress continues to be made into the molecular mechanisms involved in bothobesity and T2D, the identification and development of safe, efficacious therapeutic modalities is significantly limited. There is an urgent need ...
SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health